Ardelyx Management
Management criteria checks 3/4
Ardelyx's CEO is Mike Raab, appointed in Mar 2009, has a tenure of 15.67 years. total yearly compensation is $4.12M, comprised of 17% salary and 83% bonuses, including company stock and options. directly owns 0.52% of the company’s shares, worth $6.55M. The average tenure of the management team and the board of directors is 4.2 years and 9.1 years respectively.
Key information
Mike Raab
Chief executive officer
US$4.1m
Total compensation
| CEO salary percentage | 17.0% |
| CEO tenure | 15.7yrs |
| CEO ownership | 0.5% |
| Management average tenure | 4.2yrs |
| Board average tenure | 9.1yrs |
Recent management updates
Recent updates
Ardelyx's Medicare Setback Casts Doubt On Long-Term Viability
Nov 14Earnings Update: Ardelyx, Inc. (NASDAQ:ARDX) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts
Nov 03
Ardelyx, Inc.'s (NASDAQ:ARDX) Shares Lagging The Industry But So Is The Business
Oct 24Is Ardelyx (NASDAQ:ARDX) Weighed On By Its Debt Load?
Aug 25Party Time: Brokers Just Made Major Increases To Their Ardelyx, Inc. (NASDAQ:ARDX) Earnings Forecasts
Aug 07Ardelyx Faces Rising Challenges Despite Revenue Growth
Aug 05Earnings Beat: Ardelyx, Inc. (NASDAQ:ARDX) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
Aug 04Ardelyx: Increased Focus On Ibsrela Due To Xphozah's Uncertain Outlook
Jul 13Why Investors Shouldn't Be Surprised By Ardelyx, Inc.'s (NASDAQ:ARDX) 25% Share Price Plunge
Jul 05Ardelyx: Strong Execution, Fairly Valued
May 10Ardelyx, Inc. (NASDAQ:ARDX) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
May 04Ardelyx Stock: A Crowded Market Curbs The Enthusiasm (Rating Downgrade)
May 03Ardelyx, Inc.'s (NASDAQ:ARDX) Popularity With Investors Is Under Threat From Overpricing
Apr 17Ardelyx Shrugs Off 'Mixed' Q4 Earnings
Mar 13Earnings Update: Ardelyx, Inc. (NASDAQ:ARDX) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts
Feb 24Ardelyx Q4 Preview: Recent Bull Run May Pause While Market Digests 2024 Guidance
Feb 20Ardelyx's XPHOZAH Still An Afterthought To The Pros
Jan 31Ardelyx: FDA Approval For Xphozah Grants Further Sales Enhancement
Jan 10Ardelyx, Inc.'s (NASDAQ:ARDX) Business Is Yet to Catch Up With Its Share Price
Jan 04Despite Lacking Profits Ardelyx (NASDAQ:ARDX) Seems To Be On Top Of Its Debt
Dec 14Party Time: Brokers Just Made Major Increases To Their Ardelyx, Inc. (NASDAQ:ARDX) Earnings Forecasts
Aug 03Rock star Growth Puts Ardelyx (NASDAQ:ARDX) In A Position To Use Debt
Jul 31Pinning Down Ardelyx, Inc.'s (NASDAQ:ARDX) P/S Is Difficult Right Now
Apr 17Is Ardelyx (NASDAQ:ARDX) Using Debt Sensibly?
Mar 30Is Ardelyx (NASDAQ:ARDX) Using Debt Sensibly?
Dec 14What To Expect For Ardelyx In The Coming Month
Oct 18CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$73m |
| Jun 30 2024 | n/a | n/a | -US$65m |
| Mar 31 2024 | n/a | n/a | -US$66m |
| Dec 31 2023 | US$4m | US$700k | -US$66m |
| Sep 30 2023 | n/a | n/a | -US$27m |
| Jun 30 2023 | n/a | n/a | -US$56m |
| Mar 31 2023 | n/a | n/a | -US$66m |
| Dec 31 2022 | US$2m | US$650k | -US$67m |
| Sep 30 2022 | n/a | n/a | -US$114m |
| Jun 30 2022 | n/a | n/a | -US$135m |
| Mar 31 2022 | n/a | n/a | -US$153m |
| Dec 31 2021 | US$4m | US$650k | -US$158m |
| Sep 30 2021 | n/a | n/a | -US$151m |
| Jun 30 2021 | n/a | n/a | -US$125m |
| Mar 31 2021 | n/a | n/a | -US$105m |
| Dec 31 2020 | US$4m | US$633k | -US$94m |
| Sep 30 2020 | n/a | n/a | -US$85m |
| Jun 30 2020 | n/a | n/a | -US$91m |
| Mar 31 2020 | n/a | n/a | -US$91m |
| Dec 31 2019 | US$2m | US$595k | -US$95m |
| Sep 30 2019 | n/a | n/a | -US$103m |
| Jun 30 2019 | n/a | n/a | -US$104m |
| Mar 31 2019 | n/a | n/a | -US$100m |
| Dec 31 2018 | US$4m | US$575k | -US$91m |
| Sep 30 2018 | n/a | n/a | -US$53m |
| Jun 30 2018 | n/a | n/a | -US$50m |
| Mar 31 2018 | n/a | n/a | -US$53m |
| Dec 31 2017 | US$5m | US$555k | -US$64m |
Compensation vs Market: Mike's total compensation ($USD4.12M) is about average for companies of similar size in the US market ($USD5.50M).
Compensation vs Earnings: Mike's compensation has increased whilst the company is unprofitable.
CEO
Mike Raab (59 yo)
15.7yrs
Tenure
US$4,118,144
Compensation
Mr. Michael G. Raab, also known as Mike, has been the Chief Executive Officer and President of Ardelyx, Inc. since March 2009. He is a Director of Tempest Therapeutics Inc. since May 2019 and its Chairman...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 15.7yrs | US$4.12m | 0.52% $ 6.5m | |
| Chief Legal & Administrative Officer and Secretary | 10.5yrs | US$1.63m | 0.081% $ 1.0m | |
| Chief Medical Officer | 4yrs | US$1.63m | 0.13% $ 1.7m | |
| Chief Financial & Operations Officer | 4.4yrs | US$1.73m | 0.12% $ 1.6m | |
| Senior VP of Finance & Principal Accounting Officer | no data | no data | 0.051% $ 637.1k | |
| Vice President of Corporate Communications & Investor Relations | no data | no data | no data | |
| Executive Vice President of Corporate Development & Strategy | less than a year | no data | no data | |
| Chief Human Resources Officer | 1.8yrs | no data | no data | |
| Chief Development Officer | 9.8yrs | US$1.63m | 0.23% $ 2.8m | |
| Chief Regulatory Affairs & Quality Assurance Officer | no data | US$1.70m | 0.13% $ 1.7m | |
| Advisor | 4.5yrs | US$1.04m | 0.19% $ 2.4m | |
| Chief Commercial Officer | less than a year | no data | no data |
4.2yrs
Average Tenure
60yo
Average Age
Experienced Management: ARDX's management team is considered experienced (4.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 15.7yrs | US$4.12m | 0.52% $ 6.5m | |
| Independent Chairman of the Board | 15.7yrs | US$249.90k | 0.60% $ 7.6m | |
| Independent Director | 9.1yrs | US$214.90k | 0.097% $ 1.2m | |
| Independent Director | 10.7yrs | US$222.40k | 0.11% $ 1.3m | |
| Independent Director | 8.4yrs | US$202.40k | no data | |
| Independent Director | 4.7yrs | US$199.90k | 0.047% $ 585.0k | |
| Independent Director | 3.7yrs | US$202.40k | 0.040% $ 508.7k |
9.1yrs
Average Tenure
59yo
Average Age
Experienced Board: ARDX's board of directors are considered experienced (9.1 years average tenure).